Search results for "Urtica"

showing 10 items of 130 documents

Management of Chronic Urticaria in a Pediatric Population

2019

Pediatricsmedicine.medical_specialtybusiness.industryImmunologyImmunology and AllergyMedicinebusinessChronic urticariaPediatric populationJournal of Allergy and Clinical Immunology
researchProduct

EAACI/GA²LEN/EDF/WAO guideline: management of urticaria

2009

This guideline, together with its sister guideline on the classification of urticaria (Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Gimenez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO Guideline: definition, classification and diagnosis of urticaria. Allergy 2009;64: 1417-1426), is the result of a consensus reached during a panel discussion at the Third International Consensus Meeting on Urticaria, Urticaria 2008, a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF) and the World Al…

Pediatricsmedicine.medical_specialtybusiness.industryImmunologyMEDLINEGuidelinemedicine.diseaseFirst line treatmentQuality of lifeFamily medicinemedicineImmunology and Allergymedia_common.cataloged_instanceEffective treatmentPhysical urticariaEuropean unionbusinessPanel discussionmedia_commonAllergy
researchProduct

Chronic Spontaneous Urticaria and Type 1 Diabetes Mellitus—Does Quality of Life Impairment Always Reflect Health Danger?

2020

Background and aims: Chronic spontaneous urticaria (CSU) and diabetes mellitus type 1 (T1DM) may compromise the quality of life (QoL). We decided to compare the QoL of T1DM patients to those suffering from CSU. Materials and methods: Sixty-six patients with well-controlled T1DM (male 52%) in the mean age of (SD) 36.3 (11.09) years and 51 patients with CSU (male 33%) in the mean age of (SD) 35.8 (8.53) years were enrolled in this observational study. All the participants completed a Short-Form 36 (SF-36) QoL. Results: The QoL related to social functioning was significantly worse among CSU patients. There were differences related to gender found in the group of patients with T1DM&mdash

Pediatricsmedicine.medical_specialtyendocrine system diseaseslcsh:Medicine030209 endocrinology & metabolismchronic urticaria; diabetes; quality of lifeArticlechronic urticaria030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of lifeDiabetes mellitusMedicineDisease management (health)Social functioningType 1 diabetesdiabetesbusiness.industrylcsh:Rnutritional and metabolic diseasesMean ageGeneral Medicinemedicine.diseasehumanitiesquality of lifeMarital statusObservational studybusinessJournal of Clinical Medicine
researchProduct

Interaction of a host plant and its holoparasite: effects of previous selection by the parasite

2001

If parasites decrease the fitness of their hosts one could expect selection for host traits (e.g. resistance and tolerance) that decrease the negative effects of parasitic infection. To study selection caused by parasitism, we used a novel study system: we grew host plants (Urtica dioica) that originated from previously parasitized and unparasitized natural populations (four of each) with or without a holoparasitic plant (Cuscuta europaea). Infectivity of the parasite (i.e. qualitative resistance of the host) did not differ between the two host types. Parasites grown with hosts from parasitized populations had lower performance than parasites grown with hosts from unparasitized populations,…

Plant ecologyInfectivitybiologyHost (biology)BotanyParasitismParasite hostingCuscuta europaeabiology.organism_classificationUrtica dioicaEcology Evolution Behavior and SystematicsObligate parasiteJournal of Evolutionary Biology
researchProduct

Urticaria in Pediatrics and During Pregnancy and Lactation: Highlights on Epidemiology, Diagnosis, and Management

2021

Chronic urticaria (CU) in children as in adults is characterized by the presence of itchy wheals, angioedema, or both daily or almost daily for at least 6 weeks. Most cases of urticaria in the pediatric age group are acute [1–4]. CU is sub-classified as spontaneous (occurring without a known trigger) or inducible. There are also cases of spontaneous and inducible forms that co-exist. The chronic subtypes occur continuously but also recurrently, often in association with infections. In this chapter we will touch briefly on the clinical presentation, diagnosis, and management of acute urticaria in children. However, our primary goal is to highlight key findings regarding the epidemiology, dia…

PregnancyPediatricsmedicine.medical_specialtyAcute urticariaAngioedemabusiness.industryPediatric agemedicine.diseasemedicine.anatomical_structureimmune system diseasesLactationEpidemiologyMedicineApproaches of managementmedicine.symptomskin and connective tissue diseasesbusinessChronic urticaria
researchProduct

Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: A systematic review

2008

In vitro and in vivo clinical and experimental data have suggested that leukotrienes play a key role in inflammatory reactions of the skin. Antileukotriene drugs, ie, leukotriene receptor antagonists and synthesis inhibitors, are a class of anti-inflammatory drugs that have shown clinical efficacy in the management of asthma and in rhinitis with asthma. We searched MEDLINE database and carried out a manual search on journals specializing in allergy and dermatology for the use of antileukotriene drugs in urticaria. Montelukast might be effective in chronic urticaria associated with aspirin (ASA) or food additive hypersensitivity or with autoreactivity to intradermal serum injection (ASST) wh…

Pulmonary and Respiratory MedicineAllergyzafirlukastmedicine.medical_treatmentleukotrienes anti-inflammatory drugsReviewCold urticariaantihistamineimmune system diseasesparasitic diseasesImmunology and AllergyMedicineZafirlukastVibratory angioedemaskin and connective tissue diseasesMontelukastbusiness.industryleukotriene receptor antagonistsZileutonmedicine.diseaseAntileukotrienechronic idiopathic urticariamontelukastImmunologyAntihistaminebusinessmedicine.drug
researchProduct

Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioede…

2022

Background Monitoring the effects of treatment on disease activity, impact, and control in patients with chronic spontaneous urticaria (CSU) is essential. We do not have enough information on how these features of CSU and its response to treatment are linked. Also, there is no information on how recurrent angioedema or coexisting chronic inducible urticaria (CIndU) affect their relation. The aim of this study was to analyse the link between disease activity, impact, and control in CSU patients and possible effects of recurrent angioedema and comorbid CIndU. Methods To perform these analyses, we validated the Polish version of the Urticaria Control Test (UCT) in 106 chronic urticaria patient…

Pulmonary and Respiratory MedicineUrticariaImmunologyValidationControlImmunology and AllergyUCTAngioedemaThe World Allergy Organization journal
researchProduct

Urticaria and bacterial infections

2014

The association between urticaria and infectious diseases has been discussed for >100 years. However, a causal relationship with underlying or precipitating infection is difficult to establish. The purpose of this work was to perform a systematic analysis of the published cases of urticaria associated with bacterial infections. We give an umbrella breakdown of up-to-date systematic reviews and other important publications on the complex association of urticaria and bacterial infections. We did a Medline search, for English language articles published until January 2014, using the key words "urticaria" and "bacteria/bacterial disease"; a second analysis was performed in groups of bacteria an…

Pulmonary and Respiratory MedicineUrticariaPATHOGENESISCHILDRENBrucellaLyme diseaseANGIOEDEMAimmune system diseasesHELICOBACTER-PYLORIMYCOPLASMA-PNEUMONIAE INFECTION; HELICOBACTER-PYLORI; LYME-DISEASE; ANGIOEDEMA; CHILDREN; BRUCELLOSIS; VASCULITIS; MANIFESTATIONS; PATHOGENESIS; EOSINOPHILIAparasitic diseasesHumansImmunology and AllergyMedicineVASCULITISskin and connective tissue diseasesBRUCELLOSISBacterial diseaseChlamydiaEOSINOPHILIAAngioedemabiologybusiness.industryLYME-DISEASEBacterial InfectionsGeneral MedicineHelicobacter pylorimedicine.diseasebiology.organism_classificationMANIFESTATIONSMycoplasma pneumoniaImmunologyMYCOPLASMA-PNEUMONIAE INFECTIONmedicine.symptombusinessPneumonia (non-human)
researchProduct

Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice

2016

Chronic spontaneous urticaria (CSU) is a skin disease that predominantly affects adults, especially women aged 20 to 40 years, and is characterized by the recurrent appearance of localized or widespread wheals, angioedema or both, without apparent external trigger. 1 , 2 Severe CSU has a detrimental effect on the quality of life and is a frequent cause of absenteeism from school and work. [3] The pathogenesis of CSU is not well understood, and it appears to have an autoimmune cause in approximately one-third of patients. [4] Guidelines for the management of CSU recommend the use of second-generation antihistamines, with the addition of leukotriene receptor antagonists, cyclosporine, or omal…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyUrticariabusiness.industryImmunologyMEDLINEOmalizumabOmalizumabDermatologyClinical PracticeAnti-Allergic Agents; Chronic Disease; Humans; Omalizumab; Urticaria; Immunology and Allergy; Pulmonary and Respiratory Medicine030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineChronic disease030228 respiratory systemAnti-Allergic AgentsChronic DiseaseHumansMedicineImmunology and AllergybusinessAnti-Allergic Agentsmedicine.drug
researchProduct

Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position…

2011

To cite this article: Baiardini I, Braido F, Bindslev-Jensen C, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, Fokkens W, Gerth van Wijk R, Giménez-Arnau A, Godse K, Grattan C, Grob JJ, La Grutta S, Kalogeromitros D, Kocatürk E, Lombardi C, Mota-Pinto A, Ridolo E, Saini SS, Sanchez-Borges M, Senna GE, Terreehorst I, Todo Bom A, Toubi E, Bousquet J, Zuberbier T, Maurer M. Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy 2011; 66: 840-844. ABSTRACT: The aim of this Global Allergy and Asthma European Network (GA(2) LEN) consensus report is to provide recommendations …

QuestionnairesClinical Trials as TopicUrticariaQuestionnaireGa2LenhumanitiesOutcome Assessment (Health Care)Treatment Outcomeimmune system diseasesSurveys and QuestionnairesOutcome Assessment Health Careparasitic diseasesChronic DiseaseQuality of LifeHumansQuestionnaires; Humans; Treatment Outcome; Clinical Trials as Topic; Quality of Life; Urticaria; Outcome Assessment (Health Care); Chronic DiseaseUrticáriaskin and connective tissue diseasesHumanQualidade de Vida
researchProduct